Unknown

Dataset Information

Interplay of m6 A and histone modifications contributes to temozolomide resistance in glioblastoma.


ABSTRACT:

Background

Despite the development of new treatment protocols for glioblastoma (GBM), temozolomide (TMZ) resistance remains a primary hindrance. Previous studies, including our study, have shown that aberrant N6-methyladenosine (m6 A) modification is implicated in GBM pathobiology. However, the roles and precise mechanisms of m6 A modification in the regulation of TMZ resistance in GBM remain unclear.

Methods

m6 A individual-nucleotide-resolution cross-linking and immunoprecipitation sequencing (miCLIP-seq) was performed to identify m6 A modification of transcripts in TMZ-resistant and -sensitive tumors. To explore the role of METTL3 in TMZ resistance, TMZ-resistant GBM cells were transfected with METTL3 shRNA or overexpression len

SUBMITTER: Li F 

PROVIDER: S-EPMC8441140 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature